Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

Pumilio 1 Activators

Pumilio 1 activators encompass a diverse group of chemical agents that enhance the biological activity of Pumilio 1 (PUM1), a member of the Pumilio family of RNA-binding proteins. PUM1 is known for its role in post-transcriptional regulation, where it typically binds to specific sequences in the 3'-untranslated regions (3'-UTRs) of target mRNAs, influencing their stability and translation. The interaction between PUM1 and mRNA is mediated by the Pumilio homology domain (PUM-HD), a conserved region that is responsible for sequence-specific RNA binding.

The activators of PUM1 function through several potential mechanisms. Some might directly interact with the protein, possibly altering its conformation in a way that enhances its affinity for RNA or its ability to repress translation. Others might act indirectly, for example, by modulating signaling pathways that affect PUM1's expression levels or by inhibiting negative regulators of PUM1, thereby increasing its functional presence within the cell. The precise mechanism by which these activators exert their effects can vary widely depending on their chemical structure and the cellular context. For instance, certain activators might prevent the phosphorylation of PUM1, a post-translational modification that could influence its activity or localization. Alternatively, some compounds may promote the interaction of PUM1 with cofactors that are necessary for its full activity.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposide is a topoisomerase II inhibitor that initiates DNA damage, subsequently activating the ATM/ATR pathway. Pumilio 1, an RNA-binding protein, is upregulated in response to this DNA damage, thereby modulating its function.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

BAY 11-7082 inhibits the NF-kB pathway by blocking IκBα phosphorylation. This blockage of the pathway alters the activity of Pumilio 1, as it is a participant in this pathway.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

MG-132 is a proteasome inhibitor, increasing the stability and activity of Pumilio 1 by preventing its degradation.

Rottlerin

82-08-6sc-3550
sc-3550B
sc-3550A
sc-3550C
sc-3550D
sc-3550E
10 mg
25 mg
50 mg
1 g
5 g
20 g
$82.00
$163.00
$296.00
$2050.00
$5110.00
$16330.00
51
(2)

Rottlerin selectively inhibits PKC delta, which can modulate the activity of Pumilio 1, as it is involved in the PKC delta pathway.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Y-27632 selectively inhibits ROCK I and II, leading to modulation of Pumilio 1, which is part of this pathway.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

SB431542 is an inhibitor of TGF-beta type I receptor ALK5 kinase, ALK4, and ALK7, which modulates the TGF-beta pathway, thus influencing Pumilio 1 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor, which modulates the JNK pathway and thereby influences Pumilio 1 activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 is an MEK inhibitor, which modulates the ERK pathway by inhibiting MEK1 and MEK2. This modulation influences Pumilio 1 activity.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin is an activator of adenylate cyclase, which increases cAMP levels and subsequently activates PKA. This activation of PKA leads to phosphorylation and activation of Pumilio 1.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

5-Aza-2'-deoxycytidine, a DNA methyltransferase inhibitor, induces DNA hypomethylation. This alteration in methylation can modulate Pumilio 1, as its function is influenced by the DNA methylation status